Factor V leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia

Elvira Grandone, Maurizio Margaglione, Donatella Colaizzo, Giuseppe Cappucci, Dario Paladini, Pasquale Martinelli, Sergio Montanaro, G. Pavone, Giovanni Di Minno

Research output: Contribution to journalArticlepeer-review


We performed a case-controlled study to investigate whether the FV Leiden mutation and the C > T677 polymorphism of the 5, 10 methylene tetrahydrofolate reductase (MTHFR) are associated with the occurrence of preeclampsia in 96 otherwise healthy preeclamptic women and 129 parous women as controls. FV Leiden carriers were 10 (10.5%) in cases and 3 (2.3%) in controls (OR: 4.9, 95% CI: 1.3-18.3). MTHFR TT homozygotes were 28 (29.8%) in cases and 24 (18.6%) in the control group (OR: 1.8, 95% CI 1.0-3.5). No difference in any of the polymorphisms was found between proteinuric (n = 45) and non-proteinuric (n = 51) patients. Moreover, MTHFR polymorphism does not affect the association between FV Leiden and preeclampsia. In conclusion, FV Leiden mutation and MTHFR TT genotype are associated with the occurrence of preeclampsia, suggesting that, during pregnancy, women carrying these gene variants are prone to develop such a complication.

Original languageEnglish
Pages (from-to)1052-1054
Number of pages3
JournalThrombosis and Haemostasis
Issue number6
Publication statusPublished - Jun 1997

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Factor V leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia'. Together they form a unique fingerprint.

Cite this